NOVO-NORDISK A/S-SPONS ADR

NVO · NYSE

Updated at 2026-10-14 08:03:32

$38.06-1.34%
Today's High
$38.89
Today’s Low
$37.98
NOVO-NORDISK A/S-SPONS ADR (NVO) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$38.85
Previous Close
$38.58
Volume
8.72M
Market Cap
$1.13T
P/E Ratio
9.71X
EPS
$26.18

Previous Day Range

$38.26$38.85

52-Week Range

$224.25$409.95

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
DRUG MANUFACTURERS - GENERAL
Headquarters
NOVO ALLE 1, BAGSVAERD, DENMARK, 2880
Country
DK
Listing Date
1974-05-17
Fiscal Year End
December
Shares Outstanding
3.39B
CIK
0000353278

Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.

Financial Metrics

Revenue

2026-06-30

$78.48B

2026-03-31

$96.82B

2025-12-31

$79.14B

2025-09-30

$74.97B

Operating Expenses

2026-06-30

$34.32B

2026-03-31

$23.6B

2025-12-31

$32.26B

2025-09-30

$33.39B

Net Income

2026-06-30

$20.98B

2026-03-31

$48.55B

2025-12-31

$26.89B

2025-09-30

$20B

Net Profit Margin

2026-06-30

26.74%

2026-03-31

50.15%

2025-12-31

33.97%

2025-09-30

26.68%

Earnings Per Share

2026-06-30

$0.96

2026-03-31

$6.63

2025-12-31

$6.04

2025-09-30

$1.02

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

$38.67B

2026-03-31

$69.2B

2025-12-31

$39.74B

2025-09-30

$33.27B

Effective Tax Rate

2026-06-30

21.9%

2026-03-31

21.89%

2025-12-31

21.33%

2025-09-30

21.59%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations. Trading related derivatives may involve leveraged losses, liquidation, and liquidity risks. Review product rules carefully before trading.